Damian Ochoa Guette

Dr. Damian Ochoa Guette

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2023 in Revista Colombiana de Reumatología
Verified
Journal Article
Closed access
ETEduardo Tuta-Quintero
Eduardo Tuta-Quintero
JSJuan C. Santacruz
Juan C. Santacruz
JCJulián Camacho
Julián Camacho
JOJuan Olivella
Juan Olivella
ECEstefanía Collazos
Estefanía Collazos
CHCamilo E. Herrera
Camilo E. Herrera

23 April 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
BPBreallan De Jesús Romero Pájaro
Breallan De Jesús Romero Pájaro
DSDiana Carolina Caicedo Sanchez
Diana Carolina Caicedo Sanchez
MLMichael Mario Vélez Lora
Michael Mario Vélez Lora
JGJohn Freddy Mina Gasca
John Freddy Mina Gasca
Damian Ochoa GuetteDamian Ochoa Guette
Damian Ochoa Guette
JRJuan David Rodriguez
Juan David Rodriguez
Sepsis-associated acute kidney injury (SA-AKI) remains a major diagnostic challenge in critically ill patients, as conventional functional criteria—serum creatinine and urine output—often detect AKI after clinically relevant pathophysiological derangement has already evolved. Increasing evidence suggests that SA-AKI reflects a heterogeneous process characterized by early cellular stress, microcirculatory dysfunction, inflammation-associated injury, and maladaptive repair preceding overt functional decline. In this context, biomarker-based approaches have been investigated to improve early risk stratification, phenotypic characterization, and prognostic assessment in septic patients. This narrative review synthesizes current evidence on established and emerging biomarkers relevant to SA-AKI, encompassing stress markers ([TIMP-2]•[IGFBP7]), tubular injury markers (e.g., NGAL, KIM-1, IL-18), functional markers (e.g., proenkephalin/penKid, cystatin C), and exploratory molecular signatures such as circulating microRNAs (miRNAs). We examine their temporal dynamics, performance estimates, and context-dependent applicability in sepsis, and discuss limitations related to heterogeneity, assay variability, and threshold standardization. Particular attention is given to multimodal and longitudinal strategies integrating biomarkers with KDIGO criteria and clinical phenotyping. Finally, we outline a stratified framework for biomarker interpretation in SA-AKI anchored to pathophysiological windows and clinical decision points. While available evidence supports the potential of selected biomarkers for short-term risk stratification and trajectory assessment, implementation requires prospective validation demonstrating incremental value beyond established models and measurable impact on patient-centered outcomes.

28 September 2026 in Reports
Verified
Journal Article
Open access
PDF file
Damian Ochoa GuetteDamian Ochoa Guette
Damian Ochoa Guette
Jennifer Patricia Vargas GómezJennifer Patricia Vargas Gómez
Jennifer Patricia Vargas Gómez
BPBreallan De Jesús Romero Pájaro
Breallan De Jesús Romero Pájaro
RBrafael andres Tous bertel
rafael andres Tous bertel
AHAmilkar José Almanza hurtado
Amilkar José Almanza hurtado
Background and Clinical Significance: Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that can closely resemble sepsis in adults, potentially delaying recognition and treatment. Because infection may trigger or coexist with HLH, persistent or disproportionate inflammation despite appropriate antimicrobial therapy should prompt reassessment for concomitant HLH and investigation of the underlying trigger; Case Presentation: We describe three adults initially managed for presumed sepsis or severe infection at a referral hospital in Colombia. All developed persistent fever, cytopenias, organomegaly, and marked hyperferritinemia. HScore values were 222, 246, and 248, respectively; the score in Case 3 was calculated retrospectively from available pretreatment data. Bone marrow hemophagocytosis was demonstrated in Cases 1 and 2 but not in Case 3. The underlying triggers were acute myeloid leukemia, disseminated histoplasmosis in the setting of advanced HIV infection, and visceral leishmaniasis. The malignancy-associated case had an unfavorable outcome. Both infection-associated cases improved after pathogen-directed therapy combined with corticosteroids to control hyperinflammation, without escalation to an etoposide-based regimen; Conclusions: Sepsis and secondary HLH should not be regarded as mutually exclusive diagnoses. Persistent or disproportionate inflammation accompanied by progressive multilineage cytopenias, splenomegaly, markedly elevated or rising ferritin levels, hypertriglyceridemia, and/or decreasing fibrinogen should prompt early HScore calculation, assessment of HLH-2004 criteria, and concurrent investigation for an underlying trigger. Recognition of the clinical pattern and individualized treatment of both the trigger and hyperinflammatory state may facilitate timely management.

10 July 2022
Verified
Journal Article
Closed access
ISIsasio Serna
Isasio Serna
LCLuisa Cabezas
Luisa Cabezas
SCSamuel Benitez Caraballo
Samuel Benitez Caraballo
ETEduardo Tuta-Quintero
Eduardo Tuta-Quintero
YMYesid Mantilla
Yesid Mantilla
SLSergio Román León
Sergio Román León

3 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Damian Ochoa GuetteDamian Ochoa Guette
Damian Ochoa Guette
Jennifer Patricia Vargas GómezJennifer Patricia Vargas Gómez
Jennifer Patricia Vargas Gómez
BPBreallan De Jesús Romero Pájaro
Breallan De Jesús Romero Pájaro
RBrafael andres Tous bertel
rafael andres Tous bertel
AHAmilkar José Almanza hurtado
Amilkar José Almanza hurtado
Background: Hemophagocytic lymphohistiocytosis is a life-threatening hyperinflammatory syndrome that can mimic sepsis in adults, delaying diagnosis and treatment. Methods: We reviewed three adult patients admitted to a high-complexity referral hospital in Colombia, all initially managed as sepsis, analyzing clinical findings, laboratory results, bone marrow studies, diagnostic approach, and outcomes. Results: All patients had persistent fever, cytopenias, organomegaly, hyperferritinemia, and hypertriglyceridemia, with ongoing inflammation despite appropriate antimicrobial therapy. Bone marrow examination showed hemophagocytosis in all cases. One case was associated with acute myeloid leukemia and had a poor outcome, while two infection-related cases, triggered by disseminated histoplasmosis and visceral leishmaniasis, improved with targeted therapy and supportive care. Conclusions: Persistent inflammation, cytopenias, and markedly elevated ferritin despite standard sepsis treatment should prompt early consideration of hemophagocytic lymphohistiocytosis and investigation of the underlying trigger.